BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29634348)

  • 1. Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism.
    Somasundaram V; Basudhar D; Bharadwaj G; No JH; Ridnour LA; Cheng RYS; Fujita M; Thomas DD; Anderson SK; McVicar DW; Wink DA
    Antioxid Redox Signal; 2019 Mar; 30(8):1124-1143. PubMed ID: 29634348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer.
    Coutinho LL; Femino EL; Gonzalez AL; Moffat RL; Heinz WF; Cheng RYS; Lockett SJ; Rangel MC; Ridnour LA; Wink DA
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression.
    Basudhar D; Somasundaram V; de Oliveira GA; Kesarwala A; Heinecke JL; Cheng RY; Glynn SA; Ambs S; Wink DA; Ridnour LA
    Antioxid Redox Signal; 2017 Jun; 26(18):1044-1058. PubMed ID: 27464521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer.
    Fionda C; Abruzzese MP; Santoni A; Cippitelli M
    Curr Med Chem; 2016; 23(24):2618-2636. PubMed ID: 27464520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling and stress: The redox landscape in NOS2 biology.
    Thomas DD; Heinecke JL; Ridnour LA; Cheng RY; Kesarwala AH; Switzer CH; McVicar DW; Roberts DD; Glynn S; Fukuto JM; Wink DA; Miranda KM
    Free Radic Biol Med; 2015 Oct; 87():204-25. PubMed ID: 26117324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOS2 as an Emergent Player in Progression of Cancer.
    Thomas DD; Wink DA
    Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage NOS2 in Tumor Leukocytes.
    BrĂ¼ne B; Courtial N; Dehne N; Syed SN; Weigert A
    Antioxid Redox Signal; 2017 Jun; 26(18):1023-1043. PubMed ID: 27397579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.
    Ambs S; Glynn SA
    Cell Cycle; 2011 Feb; 10(4):619-24. PubMed ID: 21293193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
    Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
    Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
    Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of nitric oxide in tumor progression and therapy.
    Hu Y; Xiang J; Su L; Tang X
    J Int Med Res; 2020 Feb; 48(2):300060520905985. PubMed ID: 32090657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production.
    Nafea H; Youness RA; Abou-Aisha K; Gad MZ
    J Cell Physiol; 2021 Jul; 236(7):5362-5372. PubMed ID: 33368266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.
    Switzer CH; Cheng RY; Ridnour LA; Glynn SA; Ambs S; Wink DA
    Breast Cancer Res; 2012 Sep; 14(5):R125. PubMed ID: 22971289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the significance of inducible nitric oxide synthase: Its impact on cancer progression and clinical implications.
    Chen T
    Cancer Lett; 2024 Jun; 592():216931. PubMed ID: 38701892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide: The Forgotten Child of Tumor Metabolism.
    Salimian Rizi B; Achreja A; Nagrath D
    Trends Cancer; 2017 Sep; 3(9):659-672. PubMed ID: 28867169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual function of nitric oxide in carcinogenesis, reappraisal.
    Engin AB
    Curr Drug Metab; 2011 Nov; 12(9):891-9. PubMed ID: 21838704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis.
    Burke AJ; Garrido P; Johnson C; Sullivan FJ; Glynn SA
    Antioxid Redox Signal; 2017 Jun; 26(18):1078-1090. PubMed ID: 28326819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.
    de Oliveira GA; Cheng RYS; Ridnour LA; Basudhar D; Somasundaram V; McVicar DW; Monteiro HP; Wink DA
    Antioxid Redox Signal; 2017 Jun; 26(18):1059-1077. PubMed ID: 27494631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of the inducible nitric oxide synthase (NOS2) splicing variant S3 promotes autophagic cell death from nitrosative stress in SW480 human colon cancer cells.
    Castro ED; Mathias PPM; Batista WL; Sato AYS; Toledo MS; de Almeida VT; Curcio MF; da Costa PE; Stern A; Monteiro HP
    Cell Biol Int; 2022 Jan; 46(1):158-169. PubMed ID: 34719858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight of nitric oxide signaling: A potential biomarker with multifaceted complex mechanism in colorectal carcinogenesis.
    Mandal P
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1766-1768. PubMed ID: 29233694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.